KEGG   DRUG: Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells)Help
Entry
D10212                      Drug                                   

Name
Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells);
Cervarix (TN)
Class
Antiviral
 DG01686  Inactivated vaccine
Remark
Therapeutic category: 6313
ATC code: J07BM02
Product: D10212<JP>
Efficacy
Active immunization (papillomavirus)
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07B VIRAL VACCINES
    J07BM Papillomavirus vaccines
     J07BM02 Papillomavirus (human types 16, 18)
      D10212  Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6313  Viral vaccines
     D10212  Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10212
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10212
BRITE hierarchy
Other DBs
PubChem: 163312243
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system